Evolution of hydrogels for cartilage tissue engineering of the knee: A systematic review and meta-analysis of clinical studies.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
01 2021
Historique:
received: 27 08 2020
accepted: 06 10 2020
pubmed: 7 11 2020
medline: 29 6 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

In recent years, studies have boosted our knowledge about the biology and disorders of articular cartilage. In this regard, the design of hydrogel-based scaffolds has advanced to improve cartilage repair. However, the efficacy of knee cartilage repair using hydrogels remains unclear. The aim of systematic review and meta-analysis was to scrutinize the efficiency of hydrogel-based therapy in correcting cartilage defects of knee (femoral condyle, patella, tibia plateau and trochlea). The search was conducted in PubMed to gather articles published from 2004/1/1 to 2019/10/01, addressing the effects of implant of hydrogel on knee joint cartilage regeneration. The Cochrane Collaboration's tool for estimating the risk of bias was applied to check the quality of articles. The clinical data for meta-analysis was recorded using the visual analog scale (VAS), Lysholm score, WOMAC, and IKDC. The guidelines of Cochrane Handbook for Systematic Reviews of Interventions were utilized to conduct the review and meta-analysis in the RevMan 5.3 software. The search resulted in 50 clinical trials that included 2846 patients, 986 of whom received cell-based hydrogel implants while 1860 patients used hydrogel without cell. There were significant differences comparing the pain scores based on the VAS (MD: -2.97; 95% CI: -3.15 to -2.79, P<0.00001) and WOMAC (MD: -25.22; 95% CI: -31.22 to -19.22, P<0.00001) between pre- and post-treatment with hydrogels. Furthermore, there were significant improvements in the functional scores based on the IKDC total score (MD: 30.67; P<0.00001) and the Lysholm knee scale (MD: 29.26; 95% CI: 26.74 to 31.78, P<0.00001). According to the Lysholm and IKDC score and after cumulative functional analysis, there was a significant improvement in this parameter (MD: 29.25; 95% CI: 27.26 to 31.25, P<0.00001). This meta-analysis indicated clinically and statistically significant improvements in the pain score (VAS and WOMAC) and the functional score (IKDC and Lysholm) after the administration of hydrogel compared to pretreatment status. So, the current evidence shows the efficiency of hydrogel-based therapy in correcting and repairing knee cartilage defects.

Identifiants

pubmed: 33157230
pii: S1297-319X(20)30203-7
doi: 10.1016/j.jbspin.2020.105096
pii:
doi:

Substances chimiques

Hydrogels 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105096

Informations de copyright

Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Seyede Atefe Hosseini (SA)

Student research committee, faculty of medicine, Mashhad university of medical sciences, Mashhad, Iran; Department of medical biotechnology and nanotechnology, faculty of medicine, Mashhad university of medical sciences, Mashhad, Iran.

Rezvan Mohammadi (R)

Student research committee, department of medical biotechnology, School of advanced technologies in medicine, Shahid Beheshti university of medical sciences, Tehran, Iran; Cellular and molecular biology research center, Shahid Beheshti university of medical sciences, Tehran, Iran.

Somaye Noruzi (S)

Student research committee, School of medicine, North Khorasan university of medical sciences, Bojnurd, Iran.

Reza Ganji (R)

Department of orthopedic surgery, School of medicine, North Khorasan university of medical sciences, Bojnurd, Iran. Electronic address: R.ganji@nkums.ac.ir.

Fatemeh Oroojalian (F)

Department of advanced sciences and technologies, School of medicine, North Khorasan university of medical sciences, Bojnurd, Iran. Electronic address: f.oroojalian@ut.ac.ir.

Amirhossein Sahebkar (A)

Biotechnology research center, pharmaceutical technology institute, Mashhad university of medical sciences, Mashhad, Iran; Neurogenic inflammation research center, Mashhad university of medical sciences, Mashhad, Iran; Halal research center of IRI, FDA, Tehran, Iran; Polish mother's memorial hospital research institute (PMMHRI), Lodz, Poland. Electronic address: sahebkara@mums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH